Effect of strontium ranelate on femur densitometry and antioxidative/ oxidative status in castrated male rats

Scandinavian Journal of Laboratory Animal Science

Volumn 36, Issue 2, 2009, Pages 193-201

  Radzki, Radoslaw P ^a   Bienko, M ^a   Filip, R ^b   Albera, E ^a   Kankofer, M ^a  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

STRONTIUM RANELATE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MINERALIZATION; CASTRATION; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; LIPID PEROXIDATION; MALE; NONHUMAN; ORCHIECTOMY; OSTEOPENIA; OXIDATIVE STRESS; RAT; TRABECULAR BONE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 76149140095     PISSN: 09013393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Alberti A, L Bolognini, D Macciantelli & Caratelli.M: The radical cation of N,N-diethylpara-phenylenediamine: a possible indicator of oxidative stress in biological samples. Res. Chem.Intermed. 2000, 26, 253-267.
2. Ammann P, V Shen, B Robin, Y Mauras, JP Bonjour & R Rizzoli: Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J.Bone Miner.Res. 2004, 19, 2012-2020.
3. Az-Flores M, LA Baiza-Gutman, NN Pedron & JJ Hicks: Uterine glutathione reductase activity: modulation by estrogens and progesterone. Life Sci. 1999, 65, 2481-2488.
4. Azevedo RB, ZG Lacava, CK Miyasaka, SB Chaves & R Curi: Regulation of antioxidant enzyme activities in male and female rat macrophages by sex steroids. Braz.J.Med.Biol.Res. 2001, 34, 683-687.
5. Baron R, Y Tsouderos: In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur.J.Pharmacol. 2002, 450, 11-17.
6. Basu S, K Michaelsson, H Olofsson, S Johansson & H Melhus: Association between oxidative stress and bone mineral density. Biochem.Biophys. Res.Commun. 2001, 288, 275-279.
7. Benzie IF, JJ Strain:The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal.Biochem. 1996, 239, 70-76.
8. Boivin G, P Deloffre, B Perrat, G Panczer, M Boudeulle, Y Mauras, P Allain, Y Tsouderos & PJ Meunier: Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J.Bone Miner.Res. 1996, 11, 1302-1311.
9. Bonnick SL: Osteoporosis in men and women. Clin. Cornerstone. 2006, 8, 28-39.
10. Brown EM, RJ MacLeod. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev. 2001, 81, 239-297.
11. Cavani F, M Fini, TF de, M Cadossi, L Ciminelli, S Ortolani, R Cherubini, AD De, G Giavaresi, R Cadossi & V Cane: Effect of trabecular orientation on mechanical resistance and ultrasound propagation in specimens of equine vertebrae. Ultrasound Med.Biol. 2003, 29, 1777-1785.
12. Chainy GB, S Samantaray & L Samanta: Testosterone-induced changes in testicular antioxidant system. Andrologia 1997, 29, 343-349.
13. Dahl SG, P Allain, PJ Marie, Y Mauras, G Boivin, P Ammann, Y Tsouderos, PD Delmas & C Christiansen: Incorporation and distribution of strontium in bone. Bone 2001, 28, 446-453.
14. Delannoy P, D Bazot & PJ Marie: Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 2002, 51, 906-911.
15. Dimai HP: Strontium ranelate: a novel concept for the treatment of osteoporosis. Wien.Klin. Wochenschr. 2005, 117, 728-738.
16. Fernandez-Garcia D, G Alonso & M Munoz-Torres: Anabolic therapy of osteoporosis. Med.Clin. (Barc.) 2005, 125, 341-345.
17. Genant HK, C Cooper, G Poor, I Reid, G Ehrlich, J Kanis et al.: Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos.Int. 1999, 10, 259-264.
18. Gomez-Zubeldia MA, R Hernandez, J Viguera, JJ Arbues, A Aparicio & JC Millan: Effect of bilateral ovariectomy and ovarian steroid hormones on the antioxidant systems and plasma malondialdehyde levels in Wistar rats. Endocr.Res. 2000, 26, 97-107.
19. Grynpas MD, E Hamilton, R Cheung, Y Tsouderos, P Deloffre, M Hott & PJ Marie: Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone 1996, 18, 253-259.
20. Hott M, P Deloffre, Y Tsouderos & PJ Marie: S12911-2 reduces bone loss induced by shortterm immobilization in rats. Bone 2003, 33, 115-123.
21. Huh K, US Shin, JW Choi & SI Lee: Effect of sex hormones on lipid peroxidation in rat liver. Arch.Pharm.Res. 1994, 17, 109-114.
22. Isomura H, K Fujie, K Shibata, N Inoue, T Iizuka, G Takebe, K Takahashi, J Nishihira, H Izumi & W Sakamoto: Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 2004, 197, 93-100.
23. Janaszewska A, G Bartosz: Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma. Scand.J.Clin. Lab Invest 2002, 62, 231-236.
24. Kume-Kick J, DC Ferris, I Russo-Menna & ME Rice: Enhanced oxidative stress in female rat brain after gonadectomy. Brain Res. 1996, 738, 8-14.
25. Lacava ZG, H Luna: The anticlastogenic effect of tocopherol in peritoneal macrophages of benznidazole-treated and ovariectomized mice. Mutat.Res. 1994, 305, 145-150.
26. Li L, FH Kruszewski, K Punnonen, RW Tucker, SH Yuspa & H Hennings. Strontium induces murine keratinocyte differentiation in vitro in the presence of serum and calcium. J.Cell Physiol 1993, 154, 643-653.
27. Lowry OH, NJ Rosebrough, AL Farr & RJ Randall: Protein measurement with the Folin phenol reagent. J.Biol.Chem. 1951, 193, 265-275.
28. Maggio D, M Barabani, M Pierandrei, MC Polidori, M Catani, P Mecocci, U Senin, R Pacifici & A Cherubini: Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J.Clin.Endocrinol.Metab 2003, 88, 1523-1527.
29. Marie PJ: Strontium ranelate: a novel mode of action optimizing bone formation and resorption. Osteoporos.Int. 2005, 16 Suppl 1, S7-10.
30. Marie PJ, P Ammann, G Boivin & C Rey: Mechanisms of action and therapeutic potential of strontium in bone. Calcif.Tissue Int. 2001, 69, 121-129.
31. Marie PJ, M Hott, D Modrowski, PC De, J Guillemain, P Deloffre & Y Tsouderos: An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J.Bone Miner.Res. 1993, 8, 607-615.
32. Meunier PJ, C Roux, E Seeman, S Ortolani, JE Badurski, TD Spector, J Cannata, A Balogh, EM Lemmel, S Pors-Nielsen, R Rizzoli, HK Genant & JY Reginster: The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N.Engl.J.Med. 2004, 350, 459-468.
33. Muthusami S, I Ramachandran, B Muthusamy, G Vasudevan, V Prabhu, V Subramaniam, A Jagadeesan & S Narasimhan: Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin.Chim.Acta 2005, 360, 81-86.
34. Naveau B. Strontium: a new treatment for osteoporosis. Joint Bone Spine 2004, 71, 261-263.
35. Persky AM, PS Green, L Stubley, CO Howell, L Zaulyanov, GA Brazeau & JW Simpkins: Protective effect of estrogens against oxidative damage to heart and skeletal muscle in vivo and in vitro. Proc Soc.Exp.Biol.Med. 2000, 223, 59-66.
36. Pors NS: The biological role of strontium. Bone 2004, 35, 583-588.
37. Quarles LD: Cation sensing receptors in bone: a novel paradigm for regulating bone remodeling? J.Bone Miner.Res. 1997, 12, 1971-1974.
38. Reginster JY, R Deroisy & I Jupsin: Strontium ranelate: a new paradigm in the treatment of osteoporosis. Drugs Today (Barc.) 2003, 39, 89-101.
39. Ries WL, LL Key, Jr. & RM Rodriguiz: Nitroblue tetrazolium reduction and bone resorption by osteoclasts in vitro inhibited by a manganesebased superoxide dismutase mimic. J.Bone Miner.Res. 1992, 7, 931-939.
40. Shorr E, AC Ccarter: The usefulness of strontium as an adjuvant to calcium in the remineralization of the skeleton in man. Bull.Hosp.Joint Dis. 1952, 13, 59-66.
41. Sies H: Strategies of antioxidant defense. Eur.J.Biochem. 1993, 215, 213-219.
42. Stubbs WP, MS Bloomberg, SL Scruggs, VM Shille & TJ Lane: Effects of prepubertal gonadectomy on physical and behavioral development in cats. J.Am.Vet.Med.Assoc. 1996, 209, 1864-1871.
43. Takahashi N, T Sasaki, Y Tsouderos & T Suda: S 12911-2 inhibits osteoclastic bone resorption in vitro. J.Bone Miner.Res. 2003, 18, 1082-1087.
44. Yalin S, S Bagis, G Polat, N Dogruer, AS Cenk, R Hatungil & C Erdogan: Is there a role of free oxygen radicals in primary male osteoporosis? Clin.Exp.Rheumatol. 2005, 23, 689-692.
45. Yamaguchi T, N Chattopadhyay, O Kifor, JL Sanders & EM Brown: Activation of p42/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line. Biochem.Biophys.Res. Commun. 2000, 279, 363-368.